31st of July 2025

Case study: >Your< Prediabetiq Line

An analysis of how our client launched our blood glucose management products in an EU market and gained a 9% market share in just 7 months post-launch.

Our client, a leading food supplement company from a country in the European Union, launched >Your< Prediabetiq Capsules in 2024. The blood glucose supplement market in their country was relatively new and not yet developed with only a few players present. Due to an extremely successful product launch campaign, our client took a 9% market share in only 7 months post-launch.

the case study.

Download the case study to discover how our client:

"*" indicates required fields

  • tested the market with various positionings of the product to learn what consumers respond to most
  • developed an app to make the presentations to doctors more appealing
  • achieved a no. 2 position in the first year post-launch

explore further.

>Your< Prediabetiq Line is a line of private label food supplements for blood glucose management
>Your< Prediabetiq Line

Support of balanced blood glucose levels through two complementary mechanisms with an immediate effect, measurable by consumers in real-time. Continuous consumption works towards long-term health goals.

Vitafoods Europe 2025 insights

Episode #7 of our podcast with market trend, product launch, and showcased ingredient highlights from Vitafoods Europe 2025.

Vitafoods Europe 2025 insights podcast by PharmaLinea

 

"*" indicates required fields

"*" indicates required fields

PharmaLinea © 2026